BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
BD is a global medical technology company that is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care.
BD Associates
Countries Served
Devices Made Annually
Annual R&D Spending
Active Patents
For complete information regarding our financials, see our periodic filings
Quarter Ended Jun 30, 2024
Q3 2024 Total BD Revenue
Q3 2024 Adjusted EPS*
For complete information regarding our financials, see our periodic filings
For Fiscal Year Ending Sep 30, 2023
Sign up today and receive company updates straight to your inbox.
BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics
Our ESG strategy—a four-pillar framework called Together We Advance—embraces the connections and interdependence between company health, planet health, community health and human health. Through this framework, we address the most relevant ESG issues for our business and stakeholders.
View ESG Efforts
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417
United States
800.284.6845
Becton, Dickinson and Company
800.284.6845
investor_relations@bd.com
Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940-3066
877.498.8861
computershare@computershare.com
https://www.computershare.com
Overnight Mail Address
150 Royall St., Suite 101
Canton, MA 02021
The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.
All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company's control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.